ZEPPOLA, TEA
 Distribuzione geografica
Continente #
AS - Asia 1.000
NA - Nord America 304
EU - Europa 154
SA - Sud America 77
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 1.552
Nazione #
SG - Singapore 749
US - Stati Uniti d'America 286
CN - Cina 106
IT - Italia 93
HK - Hong Kong 75
BR - Brasile 59
VN - Vietnam 29
FR - Francia 15
GB - Regno Unito 15
AR - Argentina 9
DE - Germania 8
ID - Indonesia 6
CA - Canada 5
IN - India 5
KR - Corea 5
MX - Messico 5
BD - Bangladesh 4
PK - Pakistan 4
AU - Australia 3
CZ - Repubblica Ceca 3
FI - Finlandia 3
JO - Giordania 3
MA - Marocco 3
NL - Olanda 3
PY - Paraguay 3
CL - Cile 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IQ - Iraq 2
JM - Giamaica 2
MD - Moldavia 2
PH - Filippine 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
ZA - Sudafrica 2
BE - Belgio 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
IL - Israele 1
KE - Kenya 1
LT - Lituania 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
SE - Svezia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TR - Turchia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 1.547
Città #
San Jose 88
Hong Kong 71
Singapore 70
Rome 68
Ashburn 45
Hefei 30
Beijing 24
Council Bluffs 23
Boardman 18
Columbus 16
Lauterbourg 14
Shanghai 14
Dallas 11
London 11
Hanoi 10
Los Angeles 9
Ho Chi Minh City 6
Santa Clara 6
São Paulo 6
Buffalo 5
Mexico City 5
Milan 5
Yeonsu-gu 5
Jinan 4
Brno 3
Munich 3
New York 3
San Francisco 3
Amman 2
Amsterdam 2
Blumenau 2
Chaguanas 2
Da Nang 2
Helsinki 2
Houston 2
Johannesburg 2
Kingston 2
Las Vegas 2
Phoenix 2
Pune 2
Rio de Janeiro 2
Safi 2
Sydney 2
Vĩnh Long 2
Abbeville 1
Abha 1
Addis Ababa 1
Alagoinhas 1
Antwerp 1
Athens 1
Atyrá 1
Avellaneda 1
Bagé 1
Barra do Garças 1
Barra do Piraí 1
Barry 1
Beni Khalled 1
Biñan 1
Bogotá 1
Boston 1
Boydton 1
Brasília 1
Bratislava 1
Bình Dương 1
Campinas 1
Campo Grande 1
Can Tho 1
Canberra 1
Carlópolis 1
Casablanca 1
Caxias do Sul 1
Cesena 1
Charlotte 1
Chicago 1
Chittagong 1
Ciudad del Este 1
Claypole 1
Clementon 1
Conselheiro Lafaiete 1
Contagem 1
Crawfordville 1
Croydon 1
Dehradun 1
Dhaka 1
Djelfa 1
Faisalabad 1
Fortaleza 1
Francisco Morato 1
Franco da Rocha 1
Gravataí 1
Guaratuba 1
Guarulhos 1
Guayaquil 1
Guernica 1
Huế 1
Hải Dương 1
Isidro Casanova 1
Islamabad 1
Istanbul 1
Itambé 1
Totale 664
Nome #
ADDIO-BTcP " Evaluation of an UCBM Algorithm-Driven calculator of initial rapid-onset opioids Dose in Italian Oncological patients suffering from breakthrough cancer pain (BTcP): a randomized, multicentric, prospective, phase II trial” 251
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable 239
Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma 219
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 160
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 97
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort 66
Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO 64
Denosumab for cancer-related bone loss 63
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 57
Prognostic and predictive factors in pancreatic cancer 56
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study 52
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice 51
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 46
Second-line chemotherapy for advanced pancreatic cancer: Which is the best option? 45
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 44
Movement-Based Interventions in Patients Affected by Bone Metastases: Impact on Physical Function and Functional Autonomy—A Systematic Review 42
Totale 1.552
Categoria #
all - tutte 8.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202216 0 0 0 0 1 0 0 0 1 0 0 14
2022/20231 0 0 0 0 0 0 0 0 0 0 1 0
2023/202460 0 5 1 3 3 24 0 6 1 0 0 17
2024/2025799 8 9 18 6 2 14 7 3 46 48 333 305
2025/2026597 49 25 37 67 35 29 177 26 63 68 12 9
2026/202779 7 64 8 0 0 0 0 0 0 0 0 0
Totale 1.552